Embryo Project Encyclopedia

The male body, followed by male reproductive organs from which the sperm originates, is depicted from top to bottom at the left. Under the male reproductive organs is a diagram of a single sperm. To the right of the sperm diagram, the physiological and morphological changes a sperm undergoes to fertilize an egg are depicted from left to right. Each change is associated with a light pink rectangle background. Each light pink rectangle corresponds to the location of the sperm within the female reproductive organs, which is depicted above it. In addition, a molecular view of each change is directly under each light pink rectangle.
It is important to note the background color of the illustration. A blue to purple gradient depicts the two phases of sperm capacitation: sperm capacitation is in blue, and the acrosome reaction is in purple. It is still unclear where the two phases differentiate and thus a gradient is used as opposed to two distinct colors. The title location for each phase designates the approximate start of each phase.

Orchiopexy, also known as orchidopexy, is a surgical technique that can correct cryptorchidism and was successfully performed for one of the first times in 1877 in Scotland. Cryptorchidism, a condition where one or both of the testicles fail to descend before birth, is one of the most common male genital birth defects, affecting approximately 2 to 8 percent of full-term male infants, and around 33 percent of premature infants. Typically in the womb, male testes form within the abdomen, then descend into the scrotal area between twenty-five to thirty-five weeks’ gestation. If one or both testicles fail to descend before birth, physicians use orchiopexy to surgically relocate the undescended testes to their normal position in the scrotum. According to many researchers, most cases of cryptorchidism do not resolve on their own, and therefore, orchiopexy surgery is often necessary. Orchiopexy, when performed before puberty, can decrease the risk of testicular cancer and infertility associated with cryptorchidism.

First manufactured in 1988 by Serono laboratories, recombinant gonadotropins are synthetic hormones that can stimulate egg production in women for use in fertility treatments. Recombinant gonadotropins are artificially created using recombinant DNA technology, a technology that joins together DNA from different organisms. In vertebrates, naturally-occurring gonadotropins regulate the growth and function of the gonads, known as testes in males and ovaries in females. Medical professionals can derive female gonadotropins from the urine of pregnant and post-menopausal women, often using it to facilitate in vitro fertilization, or IVF. With the rapid development of assisted reproductive technologies like IVF, demand for human-derived gonadotropins rose to a global yearly demand of 120 million liters of urine by the beginning of the twenty-first century, which resulted in a demand that could not be met by traditional technologies at that time. Therefore, researchers created recombinant gonadotropins to establish a safer and more consistent method of human gonadotropin collection that met the high demand for its use in fertility treatments.

The Chicago Women’s Liberation Union, hereafter Union or CWLU, was a feminist union that operated in Chicago, Illinois, from 1969 to 1977 and was the first and largest union, at the time of its operation, focused on women’s issues. The Union organized women with the self-proclaimed collective goal of achieving liberation from sexism and inequality. Within the larger CWLU, smaller groups and chapters formed to address issues such as abortion, rape, child care, and reproductive health, among others. During CWLU’s eight years of operation, the activists circulated petitions, held demonstrations, and visited high schools to raise public awareness of women’s issues. The CWLU created educational opportunities for women in response to apparent sexism in the US and connected them to social groups to further the women’s liberation movement and women’s reproductive health awareness in the United States.

NovaSure is a device for endometrial ablation, which is a procedure that removes the endometrium, that the US Food and Drug Administration, or FDA, approved for use on 28 September 2001. Endometrium is the tissue that lines the uterus. NovaSure destroys the endometrium by sending electric beams at the endometrium. Hologic, a medical technology company concerned with women’s health, developed NovaSure to treat menorrhagia, or heavy bleeding during menstruation. Menorrhagia is a common symptom of endometriosis. Endometriosis is the growth of the endometrium outside of the uterus. While NovaSure is not a treatment that doctors use to directly treat endometriosis, the procedure may help alleviate heavy bleeding during menstruation, which may improve a patient’s quality of life as heavy menstrual bleeding is often associated with high levels of anxiety and low levels of confidence.

The Boston Women’s Health Book Collective was a women’s health organization headquartered in Boston, Massachusetts, that published the informational book Our Bodies Ourselves, which sold over 4.5 million copies. Initially called the Doctor’s Group, the Collective formed in response to the insufficiency of women-specific health information during the late 1960s and early 1970s. Members of the organization participated in the women’s liberation movement in Boston, Massachusetts, and conducted research on women’s health using resources such as medical textbooks. They collectively created an original publication surrounding women’s health concerns and offered educational courses for women to learn more about their bodies and to share their experiences. The Boston Women’s Health Book Collective, later called Our Bodies Ourselves, expanded access to women’s health information throughout the world with their publications, courses, and outreach.

The United States Food and Drug Administration, or FDA, published 'General Considerations for the Clinical Evaluation of Drugs,' in September 1977. The document defined acceptable practices for investigators who studied new drugs. Specifically, the document outlined the common clinical trial methods. Clinical trials are studies to test whether a new drug is safe before doctors can prescribe it to patients. Prior to 1977, the Protection of Human Subjects Rule primarily regulated clinical drug trials, but it did not specify who could and could not be included in clinical trials. In the document, the FDA recommended that anyone who could become pregnant be excluded from early-phase clinical trials to minimize risks to a potential fetus. After the FDA published the document, investigators excluded women from clinical trials. The document ultimately prevented women of reproductive capacity from participating in early phase clinical trials, which affected women’s health research.

In 1973, Ronald Ericsson developed the Ericsson method, which is a technique used to separate human male sperm cells by their genetic material. Ericsson, a physician and reproduction researcher, developed the method while conducting research on sperm isolation in Berlin, Germany, in the early 1970s. He found that the sperm cells that carry male-producing Y chromosomes move through liquid faster than the cells that carry female-producing X chromosomes. As a result of his findings, Ericsson suggested suspending a semen sample in a viscous liquid made from albumin protein, and collecting only sperm that quickly pass through the liquid. Shortly after Ericsson described his method, researchers demonstrated that it was effective for sex selection. However, later studies contested those results. Despite that, the Ericsson method is still utilized by couples in 2018 as a means of sex selection and was the first sperm separation technique used in combination with artificial insemination to enable people to select the sex of their children.

Torsten Nils Wiesel studied visual information processing and development in the US during the twentieth century. He performed multiple experiments on cats in which he sewed one of their eyes shut and monitored the response of the cat’s visual system after opening the sutured eye. For his work on visual processing, Wiesel received the Nobel Prize in Physiology or Medicine in 1981 along with David Hubel and Roger Sperry. Wiesel determined the critical period during which the visual system of a mammal develops and studied how impairment at that stage of development can cause permanent damage to the neural pathways of the eye, allowing later researchers and surgeons to study the treatment of congenital vision disorders.

In the book Your Baby’s Sex: Now You Can Choose, David Michael Rorvik and Landrum Brewer Shettles describe methods that couples can use prior to and during conception that will increase the chances of producing a child of their desired sex. Rorvik, a science writer, and Shettles, an obstetrics and gynecology researcher and physician, co-wrote the book. Shettles developed the methods detailed in the book during the 1960s. Although the authors claim a high success rate, some researchers have contested the validity of the methods proposed in Your Baby’s Sex: Now You Can Choose. Despite contradicting evidence for the effectiveness of the methods, the book itself has remained popular throughout its forty consecutive years in print. Since its original publication, Your Baby’s Sex: Now You Can Choose has reached a large audience, with over 1.5 million copies of the book sold worldwide, while adding to the controversy about the ethics of sex selection research.